carvacrol has been researched along with 2019 Novel Coronavirus Disease in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 3 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| de Albuquerque Júnior, RLC; de Carvalho, FO; de Souza Araújo, AA; Nunes, PS; Silva, ÉR; Silva, JPR | 1 |
| Bartkowiak, A; Mizielińska, M; Nawrotek, P; Ordon, M; Stachurska, X | 1 |
| Jaiswal, A; Singh, RK; Yadav, PK | 1 |
1 review(s) available for carvacrol and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Would carvacrol be a supporting treatment option effective in minimizing the deleterious effects of COVID-19?
Topics: Animals; Anti-Infective Agents; Anti-Inflammatory Agents; Antioxidants; COVID-19; COVID-19 Drug Treatment; Cymenes; Cytokine Release Syndrome; Humans; Inflammation Mediators | 2021 |
2 other study(ies) available for carvacrol and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Packaging Covered with Antiviral and Antibacterial Coatings Based on ZnO Nanoparticles Supplemented with Geraniol and Carvacrol.
Topics: Acyclic Monoterpenes; Anti-Bacterial Agents; Antiviral Agents; Bacteriophages; COVID-19; Cymenes; Drug Carriers; Gram-Negative Bacteria; Gram-Positive Bacteria; Metal Nanoparticles; SARS-CoV-2; Zinc Oxide | 2021 |
In silico study on spice-derived antiviral phytochemicals against SARS-CoV-2 TMPRSS2 target.
Topics: Antiviral Agents; COVID-19; Humans; Molecular Docking Simulation; Phytochemicals; SARS-CoV-2; Serine Endopeptidases; Thymol | 2022 |